The tissue engineering market is gaining substantial attention since it is a robust market with loads of medical variables. It is an interrelated field that applies methods and fundamentals of bioengineering, life science and material science. All these put together constitute the basic framework for tissue engineering. A common principle of tissue engineering comprises combination of living cells with a synthetic and natural support to produce a living construct that is functional, structural and mechanically equivalent and better that the tissue for reconstitution. There has been much debate about the progress of this field and the developmental process is ongoing. Scientists and researchers opine that much work needs to be done towards tissue and organ replacement. For this purpose, the cell source should be viable, optimal designs for scaffold and in vitro bioreactors should be deployed to its largest.
The market driving factors include rise in medical science, medical advances, organ donation and increase in drug production for tissue replacements. In addition, advances in the medical technology coupled with rise in patient pools and the demand for organ transplant is likely to develop the market growth at a faster pace.
The raw materials used for tissue engineering include biomimetic materials, composite materials, nano-composite material and nano-fibrous materials. Nano-fibrous material enjoys a leading position this segment.
Application areas for tissue engineering include dental, cardiology, urology, cancer, musculoskeletal and spine.
North America dominates the tissue engineering market owing to enhanced medical infrastructure and rise in financial support by government, increase in healthcare spending and wide presence of major players. European regions account for a leading position in the international market due to the substantial investments made through sources such as angel investors and crowdfunding. Asia-Pacific market receives an overwhelming response, as the market size is considerably large along with rise in population, road accidents, domestic injuries and frequent hospitalization of patients suffering from accidents. Cost-effective medical services are added factors responsible for the APAC market growth.
Prominent players profiled in the tissue engineering market include Allergan, ACell, Acelity, Athersys, Biotime, B.Braun, Bio Tissue Technologies, Baxter, Cook, C.R. Bard, DePuy Synthes Companies, DSM, Episkin, Organogenesis, Osiris Therapeutics, J-TEC and Zimmer Biomet.